Company Information

GENNEX LABORATORIES LTD.

NSE : NABSE : 531739ISIN CODE : INE509C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE16.08-0.18 (-1.11 %)
PREV CLOSE ( ) 16.26
OPEN PRICE ( ) 16.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 679693
TODAY'S LOW / HIGH ( )15.90 16.42
52 WK LOW / HIGH ( ) 5.7521.89
NSE
This Company is not listed in NSE
Managing DirectorArihant Baid
Company SecretaryDinesh Kumar Kejriwal
Non Executive DirectorARR Pantulu
Non Executive Independent DirectorY Ravinder Reddy
Sadhana Bhansali
A S Nageswar Rao
Incorporation Year : 1990

Registered Office :

Address : Sy . No . 133,Ida Bollaram,Jinnaram Mandal Sangareddy,
Telangana-502325 .

Phone : 08458-279406

Email :  info@gennexlab.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,Ahmedabad, Hyderabad, Kolkata

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.